1. Home
  2. SKT vs ICUI Comparison

SKT vs ICUI Comparison

Compare SKT & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tanger Inc.

SKT

Tanger Inc.

HOLD

Current Price

$40.50

Market Cap

4.7B

Sector

Real Estate

ML Signal

HOLD

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$148.27

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKT
ICUI
Founded
1981
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
3.6B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
SKT
ICUI
Price
$40.50
$148.27
Analyst Decision
Hold
Strong Buy
Analyst Count
6
3
Target Price
$37.17
$169.00
AVG Volume (30 Days)
952.7K
261.1K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
3.18%
N/A
EPS Growth
N/A
100.62
EPS
0.24
1.20
Revenue
N/A
$2,231,262,000.00
Revenue This Year
$0.37
N/A
Revenue Next Year
$3.90
$4.46
P/E Ratio
$171.29
$123.97
Revenue Growth
N/A
N/A
52 Week Low
$29.24
$107.02
52 Week High
$41.20
$160.29

Technical Indicators

Market Signals
Indicator
SKT
ICUI
Relative Strength Index (RSI) 64.26 65.05
Support Level $35.18 $146.59
Resistance Level $41.03 $153.00
Average True Range (ATR) 0.94 4.63
MACD 0.13 0.42
Stochastic Oscillator 80.21 79.92

Price Performance

Historical Comparison
SKT
ICUI

About SKT Tanger Inc.

Tanger Inc is an owner and operator of outlet and open-air centers in the United States and Canada. It is a fully-integrated, self-administered and self-managed REIT, which focuses on developing, acquiring, owning, operating and managing outlet and open-air shopping centers. Its consolidated portfolio consisted of 31 outlet centers and 2 open-air lifestyle centers.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: